A new study published in JAMA: The Journal of the American Medical Association assesses the process for Food and Drug Administration (FDA) approval of high-risk cardiac devices.
In a research finding that will add to doubts about the value of breast cancer screening, Canadian researchers determined that women ages 40 to 59 who had yearly mammograms enjoyed no added survival benefit up to 25 years later compared with those who skipped the screening X-rays.
